- Industrial
hemp to be removed from the list of controlled substances under U.S.
federal law
- Proposed
licensing agreement with VitaMist for exclusive rights in the global Asian
market for a new sprayable vitamin and vitamin/CBD product line
- Company
recently announced the appointment of a chief financial officer of CBD
Biotech, its CBD spin-off and wholly owned subsidiary
ChineseInvestors.com, Inc. (OTCQB: CIIX), the premier
financial information website for Chinese-speaking investors, is increasingly
enthusiastic about the unique role it is playing within the cannabis industry
as laws change globally.
The Agriculture Improvement Act of 2018, also known as the
farm bill, recently passed in the United States House of Representatives and
the Senate. It was also signed by President Trump (http://ibn.fm/ELcOR). This bill includes Sen. Majority
Leader Mitch McConnell’s Hemp Farming Act, which removes industrial hemp from
the list of controlled substances under federal law. This is good news for
CIIX, which recognized the opportunities in the U.S. early on. The company has
offices located in the U.S. and China, representing a key link between the U.S.
and global Chinese community, and it is working on creating additional CBD
products in nutrition and cosmetics.
In addition to the changing laws in the United States, CIIX
is excited about its new ventures. In a recent press release (http://ibn.fm/2NWRw), the
company announced its intent to enter into a licensing agreement with VitaMist
Ltd.
In 1985, VitaMist was awarded the first patent ever for a
spray vitamin and has established itself over the years as a recognized brand
with over three million individual product sales. Its innovative spray
technology, brand recognition, 30 years in the industry and 40+ proprietary
vitamin formulas represent a significant addition to CIIX as the company
expands product lines globally. “We truly believe,” CIIX CEO Warren Wang stated
in a news release, “VitaMist’s innovative and effective delivery system is the
future for CBD consumption.”
VitaMist CEO Richard Heineck is equally optimistic regarding
the upcoming new sprayable vitamin and vitamin/CBD product line that will be
designed exclusively for CIIX and the global Asian market, referring to the
proposed licensing agreement as a “grand slam!” VitaMist’s delivery
system and precise dosing methodology and CIIX’s focus on the Asian consumer
market all play into making these two companies a promising pair.
Wang expressed excitement at being a part of expanding reach
into the global industrial hemp industry. The company’s ties to the Asian
consumer market are strong, and, with South Korea becoming the first East Asian
country to legalize marijuana for medical purposes, Wang is hopeful that
Thailand will soon follow.
The company is one step closer in the process of spinning
off its CBD division through the appointment of new leadership. Alex Hamilton
has been appointed to the position of chief financial officer of CIIX’s wholly
owned subsidiary, CBD Biotechnology, Ltd. (http://ibn.fm/VgZO0). Hamilton joins Summer Yun, CEO of CBD
Biotech. Hamilton has been appointed to oversee the spin-off of the CBD
division under the guidance of Wang, freeing CIIX to refocus on its core
financial services and media business.
CIIX is a leading financial information website for
Chinese-speaking investors throughout the United States, Canada and China. The
company is laying the groundwork to capitalize on the growing demand for
CBD-based nutrition and health products. The development of new product lines
with VitaMist is only a small part of a much larger, globally-focused business
plan.
For more information, visit the company’s website at www.ChineseInvestors.com
About QualityStocks
QualityStocks is
committed to connecting subscribers with companies that have huge potential to
succeed in the short and long-term future. It is part of our mission statement
to help the investment community discover emerging companies that offer
excellent growth potential. We offer several ways for investors to learn more
about investing in these companies as well as find and evaluate them.
QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the
QualityStocks website applicable to all content provided by QS, wherever
published or re-republished: http://www.qualitystocks.net/disclaimer.php
No comments:
Post a Comment